Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
Daniel D. Von Hoff(Translational Genomics Research Institute), Catherine Griffin, Douglas E. Mattox(Emory University), Bruce W. Dana(Unknown), D S Alberts(The University of Texas at Austin), Stanley W. Coulthard, M Manning, Jane Myers
PubMed
January 1, 1981
Cited by 8
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
|Annals of Oncology|1996|569
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
|Nature Communications|2015|484